Control Bionics Statistics

Total Valuation

Control Bionics has a market cap or net worth of AUD 24.31 million. The enterprise value is 21.49 million.

Market Cap	24.31M
Enterprise Value	21.49M

Important Dates

The last earnings date was Monday, February 23, 2026.

Earnings Date	Feb 23, 2026
Ex-Dividend Date	n/a

Share Statistics

Control Bionics has 411.96 million shares outstanding. The number of shares has increased by 41.23% in one year.

Current Share Class	411.96M
Shares Outstanding	411.96M
Shares Change (YoY)	+41.23%
Shares Change (QoQ)	+11.73%
Owned by Insiders (%)	15.13%
Owned by Institutions (%)	4.93%
Float	138.56M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.01
PB Ratio	3.14
P/TBV Ratio	7.73
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.31
EV / Sales	3.54
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.81

Financial Position

The company has a current ratio of 2.22, with a Debt / Equity ratio of 0.03.

Current Ratio	2.22
Quick Ratio	1.98
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-0.05
Interest Coverage	-61.87

Financial Efficiency

Return on equity (ROE) is -91.56% and return on invested capital (ROIC) is -50.84%.

Return on Equity (ROE)	-91.56%
Return on Assets (ROA)	-40.30%
Return on Invested Capital (ROIC)	-50.84%
Return on Capital Employed (ROCE)	-77.87%
Weighted Average Cost of Capital (WACC)	4.63%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.65
Inventory Turnover	4.71

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +47.50% in the last 52 weeks. The beta is 0.02, so Control Bionics's price volatility has been lower than the market average.

Beta (5Y)	0.02
52-Week Price Change	+47.50%
50-Day Moving Average	0.06
200-Day Moving Average	0.05
Relative Strength Index (RSI)	49.10
Average Volume (20 Days)	269,521

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Control Bionics had revenue of AUD 6.07 million and -6.50 million in losses. Loss per share was -0.02.

Revenue	6.07M
Gross Profit	3.81M
Operating Income	-6.05M
Pretax Income	-6.50M
Net Income	-6.50M
EBITDA	-5.26M
EBIT	-6.05M
Loss Per Share	-0.02

Full Income Statement

Balance Sheet

The company has 3.06 million in cash and 238,271 in debt, giving a net cash position of 2.82 million or 0.01 per share.

Cash & Cash Equivalents	3.06M
Total Debt	238,271
Net Cash	2.82M
Net Cash Per Share	0.01
Equity (Book Value)	7.73M
Book Value Per Share	0.02
Working Capital	2.63M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4.13 million and capital expenditures -337,990, giving a free cash flow of -4.46 million.

Operating Cash Flow	-4.13M
Capital Expenditures	-337,990
Free Cash Flow	-4.46M
FCF Per Share	-0.01

Full Cash Flow Statement

Margins

Gross margin is 62.85%, with operating and profit margins of -99.73% and -107.04%.

Gross Margin	62.85%
Operating Margin	-99.73%
Pretax Margin	-107.04%
Profit Margin	-107.04%
EBITDA Margin	-86.64%
EBIT Margin	-99.73%
FCF Margin	n/a

Dividends & Yields

Control Bionics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-41.23%
Shareholder Yield	-41.23%
Earnings Yield	-26.72%
FCF Yield	-18.37%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Control Bionics has an Altman Z-Score of -2.63 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.63
Piotroski F-Score	2